Erin Schumaker talks with host Ruth Reader about the prospect of developing next-generation non-hallucinogenic versions of drugs such as psilocybin to treat brain disorders like depression, post-traumatic stress disorder and addiction, and the regulatory barriers that researchers who want to study psychedelics are up against.

Learn more about your ad choices. Visit megaphone.fm/adchoices